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Laboratory Testing of Transovarial Transmission in
Aedes Aegypti Mosquito
ABSTRACT
Introduction: Ae. aegypti is one of the vectors causing Dengue Hemorrhagic Fever (DHF) that feeds
on human blood suffering from DHF and transmit it to another healthy human. The ability of Dengue
Virus (DENV) to survive in nature is due to 2 mechanisms i.e. horizontal transmission among viremic
vertebratae infected by Aedes mosquitos and vertical (transovarial) transmission from infected female
mosquito to another generation.
Objectives: To know the differences between next generation’s viral carriage, percentage of mosquito
descendants carrying DENV, and the distribution of DENV in its infected mosquitos.
Methods: Study design was a quasi experimental posttest-only design with control group. The study
was conducted on 53 second-generation female Ae. aegypti mosquitos which are grouped into
treatment and control groups. Dengue Viral antigen in both groups were detected by
immunohistochemistry method using Streptavidin Biotin Peroxidase Complex (SBPC) in paraffin
embedding preparation of mosquitos aged 1-7 days. Fisher exact test was used to compare proportion
of virus detected in moaquitos between 2 groups.
Results: The virus detected in second generation of DEN-infected and uninfected mosquitos were
100% and 85.7%, respectively. The virus was distributed from day 1 to 7 in all organs such as brains,
thorax, salivary gland, gastric epithelial cells, and ovarium of the infected mosquitos. Similar
distribution was not detected in control mosquitoes.
Conclusion: There was no difference in next mosquito generation’s transovarial infection among
DENV-infected and uninfected Ae. aegypti mosquitos.
Keywords: Ae. aegypti mosquito; Dengue virus (DENV ); transovarial transmission;
immunohistochemistry method, Streptavidin Biotin Peroxidase Complex (SBPC).
INTISARI
Pendahuluan: Ae. aegypti adalah salah satu jenis nyamuk vektor penyebar penyakit Demam Berdarah
Dengue (DBD), yaitu penyakit yang ditularkan melalui gigitan nyamuk Aedes yang menggigit penderita
DBD kemudian ditularkan kepada orang sehat. Kemampuan virus Dengue (DEN) untuk
mempertahankan keberadaannya di alam dilakukan melalui dua mekanisme, yaitu transmisi
horizontal antara vertebrata viremia yang ditularkan oleh nyamuk Aedes dan dengan transmisi vertikal
(transovarial) yaitu dari nyamuk betina infektif ke generasi berikutnya.
Tujuan: Mengetahui ada tidaknya perbedaan antara nyamuk Ae. aegypti yang diinfeksi virus DEN
dengan yang tidak dalam hal kandungan virus pada keturunan selanjutnya, persentase keturunan
nyamuk yang mengandung virus DEN, serta persebaran virus DEN pada tubuh nyamuk.
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Metode: Penelitian ini menggunakan metode quasi experimental dengan desain penelitian post only
design with control group terhadap 53 ekor nyamuk Ae. aegypti betina generasi kedua. Sampel
kemudian dibagi menjadi kelompok intervensi dan kontrol. Pada kedua kelompok dilihat kandungan
virusnya dengan metode imunohistokimia Streptavidin Biotin Peroxidase Complex (SBPC) pada sediaan
embedding paraffin pada nyamuk berumur 1-7 hari, kemudian proporsi virus yang telah didapat dari
2 kelompok dianalisis menggunakan formula Fisher exact test.
Hasil: Hasil penelitian menunjukkan kandungan virus DEN pada generasi ke II kelompok intervensi
mencapai 100 % dan 85,7 % pada kelompok kontrol. Persebaran virus pada kelompok intervensi
terjadi secara merata pada hari 1-7 di setiap organ seperti otak, thorax, kelenjar saliva, sel epitel,
lambung, dan ovarium set, sedangkan pada kelompok kontrol persebarannya tidak merata.
Simpulan: Tidak ada perbedaan antara nyamuk Ae. aegypti yang diinfeksi virus DEN dengan yang
tidak diinfeksi virus (kelompok kontrol) dalam hal adanya infeksi transovarial pada nyamuk keturunan
selanjutnya.
Kata kunci: Nyamuk Ae. aegypti, virus Dengue (DEN), transmisi transovarial, metode imunohistokimia,
Streptavidin Biotin Peroxidase Complex (SBPC).
INTRODUCTION
Ae. aegypti is a common type of mosquito
to Indonesian societies because this type of
mosquito is one of the vectors transmitting
Dengue Hemorrhagic Fever (DHF). Dengue
Hemorrhagic Fever (DHF) is a Dengue viral
infectious disease (DEN) transmitted by the bite
of Aedes mosquitoes (Stegomyia), primarily
Aedes (Stegomyia) aegypti (Linaeus)1,2,3. This
type of Dengue attacks more than 100 countries
in the tropics and subtropics with more than 2.5
billion people suffering this disease. It means
that most of the world’s population is at risk of
developing this disease.
The role of Ae. aegypti mosquitoes as a
disseminator of Dengue Virus (DENV) has been
revealed since the announcement by Cleland,
Brandley, and Mc. Donald in 1916 supported in 1923
by Chandler and Rice4. Rosenau explained that Ae.
aegypti and Ae. albopictus (Skuse) in an optimum
state are capable of transmitting the virus.
Transovarial transmission of DENV in
Indonesia was first conducted in 2004 by
Umniyati5 in Klitren Village of Yogyakarta using
immunohistochemical methods of Streptavidin
Biotin Peroxidase Complex (SBPC) on head
squash of mosquitoes. The result showed that
the Transovarial Infection Rate (TIR) of for Ae.
aegypti mosquitoes was 27.27%, resulted from
the colonies between pupae and larvae obtained
from wells. The method which was then
standardized by Umniyati raises a strong
presumption that Ae. aegypti mosquitoes play
an important role in maintaining the DENV
innature, particularly when climatic conditions
are not favorable for mosquitoes6. This method
is highly sensitive, specific, reliable, and valid
for the diagnostic purposes of DENV infection in
Ae. aegypti mosquitoes7.
Since there has been no causal therapy and
immunization with vaccines that are effective
to prevent dengue infection, understanding in
depth knowledge of the epidemiological aspects
of DHF mainly the ones associated with disease
agents (DENV), their host (humans and mosquito
vectors), and environmental factors become
significant. Particularly, vector control strategy
remains the most possible method to overcome
this problem. Control of mosquito vectors
especially for Ae. aegypti has a strategic position,
i.e. in the short term, to stop transmission of
DENVes taken by vectors and in the long term,
to prevent the expansion of endemic areas2.
This study aimed to determine whether
there is a difference between the Ae. aegypti
mosquitos infected with DENVes compared with
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the ones that are not in terms of virus content
on the next offspring.
MATERIALS AND METHODS
This study was a quasi-experimental study,
the design of this study was post only design with
control group, in which the researcher measured
the effect of the intervention by assessing the
control group.
The subjects of this research were Ae.
aegypti mosquitoes which were then divided
into 2 groups. The treatment group consisted of
Ae. aegypti mosquitoes infected orally by DENV,
whereas the control group consisted of Ae.
aegypti mosquitoes that were not infected by
DENV. The research population were all Ae.
aegypti mosquitoes which were the second
offspring of the parent mosquitoes (parent
mosquitoes were not examined). The sample
was some female Ae. aegypti mosquitoes which
constituted the second offspring of the parent
mosquitoes. Then, the spread of the virus in the
sample was analyzed from the first day until the
seventh day. The samples used for each
intervention were 35 female Ae. aegypti
mosquitoes of the second offspring. In so doing,
the total number of samples required was as
many as 70 female Ae. aegypti mosquitoes of
the second offspring. Having been matched with
the inclusion and exclusion criteria, the size of
the sample was reduced to 53 female Ae. aegypti
mosquitoes of the second offspring, consisting
of 32 second-offspring mosquitoes derived from
parent mosquitoes infected by viruses and 21
mosquitoes derived from parent mosquitoes
that were not infected by viruses.
Initially, 30 female Ae. aegypti mosquitoes
of the first offspring and 30 cages equipped with
an egg trap (ovitrap tubes) were prepared. Then,
each treatment sample was given a code. The
mosquitoes were divided into 2 groups (each
group consist of 15 mosquitoes). Group I was
infected with the DENV-3 (i.e., the mosquitoes
were given the opportunity to suck blood missed
with the suspension of the virus and sucrose 10%
at a ratio of 1:1:1 through membrane feeding until
they felt full), while group II was not infected
(as a control).
Each mosquito was maintained individually
in cages within which there was an ovitrap for 7
days until they laid their eggs. Every day, the
mosquitoes were fed with sucrose 10% absorbed
in cotton inserted on the cover of the cage made
of gauze. Once the mosquitoes lay eggs, the eggs
were separated into 2 containers. The first
container contained eggs from parent
mosquitoes infected with viruses while the
second one contained eggs from parent
mosquitoes that were not infected with viruses.
The eggs that had been classified earlier
were incubated in plastic trays containing water,
and as soon as they hatch the larvae were fed
with chicken livers that had been frozen until
dried in the refrigerator. Larvae that had turned
into a pupa were taken and moved into a small
plastic cup which was later put in a cage. Pupae
that hatch into mosquitos were moved to
another cage and their age was recorded. As
many as 5 mosquitoes aged 1 day, 2 days, 3 days,
4 days, 5 days, 6 days, and 7 days were taken
both from the treatment group and the control
group, then they were taken to the Anatomic
Pathology Laboratory for the process of
mosquitoes’ tissue slices (paraffin embedding).
After paraffin embedding, the distribution
and the content of the virus was determine with
immunohistochemistry methods of SBPC using
monoclonal antibodies DSSE10 as primary
antibodies in mosquito organs such as brain cells,
thorax, salivary glands, gastric epithelial cells,
and ovarium. The detection of the content and
distribution of DENV-3 was performed under a
light microscope at a magnification of 1000x.
Positive results were indicated with brown color
and negative results were indicated with blue
color.
The data obtained was calculated and the
results were analyzed with Fisher exact test.
RESULTS AND DISCUSSIONS
The total number of the samples of female
Ae. aegypti mosquitoes of the second offspring
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Table 1. A comparison of the number of samples between each group
Definition:
Treatment group : Ae. aegypti mosquitoes obtained from parent
mosquitoes infected with viruses.
Control group : Ae. aegypti mosquitoes obtained from parent
mosquitoes that were not infected with viruses.
(+) : Ae. aegypti mosquitoes that were proved to contain
a virus after an investigation had been made.
(-) : Ae. aegypti mosquitoes that were proved to contain
no viruses after an investigation had been made.
(X) : Ae. aegypti mosquitoes that did not comply with
the inclusion criteria (excluded) after an
investigation had been made.
Table 1 showed that there were 4 groups as
follow: infected treatment group (32
mosquitoes), non-infected treatment group (0
mosquitoe), infected control group (18
mosquitoes) and non-infected control group (3
mosquitoes). In addition, 17 mosquitoes were
excluded, 3 from the treatment group and 14
from the control group.
The Fisher exact test analysis showed that
the treatment and control groups, both of which
originally were derived either from the Ae.
aegypti mosquitoes infected with viruses or the
ones that were not infected with viruses was
not significantly different (p = 0.057). In other
words, the proportion of Ae. aegypti mosquitoes
containing viruses in the treatment and control
groups did not differ significantly, which at the
same time prove the occurrence of transovarial
virus infection.
Every day for seven days, 5 Ae. aegypti
mosquitoes each from treatment and control
groups were examined. Figure 1 showed a
comparison of the percentage of the Ae. aegypti
mosquitoes from the treatment group and the
control group that were infected with viruses
since Day 1 to Day 7.
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Figure 1. A comparison between the percentage of Ae. aegypti mosquitoes from the
treatment group (blue) and the control group (red) that were infected with
viruses since Day 1 to Day 7.
From the treatment group, the number of
samples starting from Day 1-7 (after being
filtered with the inclusion and exclusion criteria)
was each 4, 4, 5, 5, 4, 5 and 5, respectively, and in
short the total number of the samples for the
treatment group was 32. Of the 32 samples of
the treatment group, it was revealed that all of
them were virus-infected (+).
From the control group, the number of
samples starting from Day 1-7 (after being
filtered with the inclusion and exclusion criteria)
was each 4, 3, 2, 3, 4, 1 and 4, respectively, and in
short the total number of the samples for the
control group was 21. Of the 21 samples of the
treatment group, it was revealed that 18 of them
were virus-infected (+) and 3 of them were not
(-). Note that Day 1 and Day 2 indicated the results
by 75% and 50 % suggesting that on those day
not all mosquitoes were infected with viruses
(+). Meanwhile, Day 6 indicated the results that
were totally negative (-). This was because from
5 mosquito samples, 4 of them were excluded
and there was only 1 sample that was truly
negative. The high number of samples excluded
was assumed to be caused by less perfect
mosquito tissue slices (paraffin embedding)
making many mosquito organs lose and finally
excluded.
Using data from the diagram above, it can
be calculated that the percentage of the infected
treatment group compared to the number of the
group’s samples is (32 / 32 x 100 %) = 100 %, while
the percentage of the infected control group and
the number of the group’s samples is: (18/21 x
100 %) = 85.7 %. There result shows that both the
treatment and control groups indicate a
proportion that was not much different. In other
words, the proportion of Ae. aegypti mosquitoes
containing viruses in the treatment and control
groups did not differ significantly.
In this study each Ae. aegypti mosquitoes was
examined in terms of the virus spread since Day 1
to Day 7 in 5 different organs (the brain, thorax,
salivary glands, gastric epithelial cells, and ovaries).
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Figure 2 A. Treatment Group
Figure 2 B. Control Group
Figure 2. Charts showing the percentage comparison of viral spread in each organ of
Ae. aegypti mosquitos from Day 1 to Day 7 among treatment (A) and control
(B) groups
Figure 2 showed that the spread of the virus
in the treatment group occurred evenly in each
organ every day since Day 1 to Day 7, while in
the control group it was not. It may be because
the treatment group consisted of the second-
offspring Ae. aegypti mosquitoes whose parent
had been infected with the virus previously,
having high level of virus, lead the spread of the
virus in the second-offspring Ae. aegypti
mosquitoes more rapid and even, while the
control group, consisted of the second-offspring
Ae. aegypti mosquitoes whose parent had not
been infected with the virus previously, having
low level of virus, lead the spread of the virus in
the second-offspring Ae. aegypti mosquitoes
that less rapid and even. However, it did not
matter because the virus remained spread in the
second-offspring mosquitoes, which also proves
the existence of the virus infection in the Ae.
aegypti mosquitoes in transovarial ways. The
DENV-3 is persistently transmitted transovarially
and its frequency increases until the 7th offspring
while its infection remains occurring in the later
offspring8.
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C. ThoraxA.Mosquitoes’ Body B. Brain
D. Mosquitoes’ Body E. Brain F. Thorax
Figure 3. Microscopic pictures of the organs of Ae. aegypti mosquitoes.
Mosquitoes’ organs that contain the DENV as positive, brown-colored
(A, B and C). Mosquitoes’ organs that do not contain the DENV as
negative, blue-colored (D, E, F)
Our results suggest that understanding the
epidemiological aspects of DHF such as disease
agents (DENV), their host and environmental
factors becomes highly significant because so far
there has been no causal therapy and
immunization with vaccines that are effective;
thereby vector control remains the only way to
overcome it.
CONCLUSION
There is no difference between Ae. aegypti
mosquitoes infected with the DENV and the ones
that were not infected with the virus (control
group) in terms of the occurrence of transovarial
infection happening to mosquitoes of the latter
offspring. The percentage of Ae. aegypti
mosquito offspring containing DENV from virus-
infected parents was 100 %, whereas for the
control group was 85.7 %. The spread of the virus
in the Ae. aegypti mosquito offspring containing
DENV from virus-infected parent occurred
evenly in the brain, thorax, salivary glands,
gastric epithelial cells, and ovaries every day
from Day 1 to Day 7, whereas for the control group
the virus did not spread evenly.
It is suggested that intensive efforts of DHF
vector control are made considering the high
content of DENV distributed to the eggs of Ae.
aegypti mosquitoes in transovarial ways. Further
research is needed on the variation of the organs
under study in order to determine the spread of
the virus in Ae. aegypti mosquitoes.
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